CASMI

‘From Adaptive Licensing to Adaptive Pathways’ paper has been published in Clinical Pharmacology & Therapeutics

policy and impact

Scientists argue that scientific and political changes will make adaptive pathways the preferred approach to make new treatments available. “Adaptive pathways should be the preferred approach in the near future to bring new medicines to patients.” A number of scientists, including members of the European Medicines Agency (EMA) and its [...]

December 17, 2014 Andrea Hodgetts CASMI News 0

Reflections on a Health Crisis

non-slider CASMI_graphic_6

Ebola is worrying, very worrying. The worst outbreak of recent times has taken thousands of lives in four West African countries and the virus has begun to appear in the US and Europe – and in one case transmitted to a local healthcare worker. The death rate from this terrible [...]

October 13, 2014 Andrea Hodgetts CASMI Views 0

CASMI IMI IMiPACT Stakeholder Platform 2014

slider CASMI_graphic_10

                                 The Innovative Medicines Initiative (IMI) and the Centre for the Advancement of Sustainable Medical Innovation (CASMI) will be holding an IMPACT Stakeholder Platform on Monday 20th October from 12 – 5pm at The Wellcome [...]

October 13, 2014 Andrea Hodgetts CASMI News 0

‘Shaping the Future of Open Innovation’ – CASMI’s latest paper for Wellcome Trust

OI report

‘Shaping the Future of Open Innovation: A practical guide for life sciences organisations‘ is the latest publication from a major CASMI project supported by the Wellcome Trust. The research was conducted in collaboration with Kinapse. Open innovation, which we define as the process of innovating with others for shared risk and reward to [...]

September 4, 2014 Andrea Hodgetts CASMI News 0

How to Succeed at Open Innovation – Rosie Pigott’s Blog for Wellcome Trust

slider CASMI_graphic_10

Blog repost from the Wellcome Trust. Read the original article here Today we launch “Shaping the Future of Open Innovation: A practical guide for life sciences organisations”, a new resource created by a collaboration led by the Wellcome Trust, the Centre for the Advancement of Sustainable Medical Innovation (CASMI) and Kinapse.Rosie Pigott from CASMI, [...]

September 4, 2014 Andrea Hodgetts CASMI Views 0

FDA uses ‘adaptive’ approach championed by CASMI for experimental Ebola treatment

CASMI_homepage_template_8

The US Food and Drug Administration (FDA) this month announced that they were lifting the hold on the experimental Ebola drug, TKM-Ebola, to allow ‘fast-tracked’ safety and efficacy studies to go ahead.  This decision was made in light of the Ebola outbreak in West Africa, which health experts are declaring as an emergency situation. [...]

August 26, 2014 Andrea Hodgetts CASMI News 0

“We are gradually going to move away from fully fledged HTAs towards more European collaboration.”

richard Bergstrom

National associations throughout Europe are engaging with governments in a whole new way. At a recent Eyeforpharma event, Richard Bergstrom, Director General of EFPIA, spoke about: – How the regulatory model is changing – The benefits of sharing expectations and the strengths and weaknesses of company data with regulators, payers and patients [...]

August 13, 2014 Andrea Hodgetts CASMI Views 0

Adaptive Licensing Report Launched by CASMI, ABPI and BIA

Sample_tubes_WEB

On 2 June 2014, the Association of the British Pharmaceutical Industry (ABPI), the BioIndustry Association (BIA) and the Centre for the Advancement of Sustainable Medical Innovation (CASMI) jointly organised a stakeholder event in London to publicise the EMA’s Adaptive Licensing pilot project. This workshop allowed pharmaceutical and biotech companies, as [...]

July 1, 2014 Andrea Hodgetts CASMI News 0

Putting Patients at the Heart of Medical Innovation

CASMI_graphic_3

It’s time that we truly put patients at the heart of medical innovation. When I say that, I don’t mean adding a token patient to a conference speaker panel or ‘box ticking’ that a pharmaceutical company has consulted a patient group. What I mean is that we need to completely [...]

June 10, 2014 Andrea Hodgetts CASMI Views 0

Adaptive licensing is a golden opportunity, but will require trust, dialogue and flexibility

AL workshop

The Association of the British Pharmaceutical Industry (ABPI), the BioIndustry Association (BIA) and the Centre for the Advancement of Sustainable Medical Innovation (CASMI) today hosted a one-stop-shop on adaptive licensing, giving medicines developers across the life sciences sector the opportunity to further enhance their understanding of how they can engage [...]

June 2, 2014 Andrea Hodgetts CASMI News 0